5:49 PM
 | 
Jul 21, 2009
 |  BC Extra  |  Financial News

Gilead beats Street

Gilead Sciences Inc. (NASDAQ:GILD) reported 2Q09 diluted non-GAAP EPS of $0.69, beating the Street's estimate of $0.61 and up 44% from $0.48 in the same period last year. Revenues rose 29% to $1.7 billion from $1.3 billion...

Read the full 166 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >